We have 6 months operating capital, it’s highly unlikely that 6 month period will contain a milestone payment from Fuji so in all likelihood expect a CR next quarter. Whilst I will be the first to admit I have no idea how to run a biotech company from the outside it appears all of the cash received from the Fidelity placement seems to have been fiddled away without a great deal to show for it. On a brighter note however the commencement of the three trials should help to support the SP.
Ann: December 2019 Quarterly Report, page-18
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $43.36M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 24.0¢ | $23.56K | 97.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18606 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |